On the recordMay 16, 2022
I think that decision is going to have some pretty long-term consequences, particularly the CMS decision.
Source
congress.govRoy Blunt: “I think that decision is going to have some pretty long-term consequences, particularly the CMS decision.”
Editor's note · Context
Blunt expresses concern about the long-term impact of FDA and CMS decisions on drug approvals.
Share
More from Roy Blunt
Dec 14, 2022
a moment ago when I saw Senator Shelby and Senator Leahy shake hands warmly in the middle of the aisle, I thought of it as a century of service in the Congress. It is a century of learning lessons that fortunately they have both been able…
Dec 18, 2022
I know I am leaving the Committee in good hands as Senator Fischer moves into the position of Ranking Member at the beginning of the next Congress.
May 6, 2023
The subcommittee is in recess until 10:00 a.m. on Thursday, May 7. Thank you all.
Other voices in this conversation
